Transition from Telmisartan to Verapamil
Telmisartan should be discontinued and verapamil should be initiated using verapamil’s labeled starting regimen for the intended indication (eg, hypertension or supraventricular rate control). [1],[2] Verapamil initiation requires monitoring for bradycardia, hypotension, and conduction abnormalities because these adverse effects can occur with verapamil. [3],[4]
Medication Selection Algorithm
Verapamil is a non-dihydropyridine calcium-channel blocker used for indications such as hypertension (typically add-on therapy) and ventricular rate control in atrial fibrillation. [1],[5] Telmisartan is an ARB used for hypertension. [6]
Transition Procedure
- Telmisartan should be stopped. [6]
- Verapamil should be started at the labeled initial dose based on formulation.
- Verapamil sustained-release (SR) for essential hypertension should be initiated at 180 mg once daily (morning). [2]
-
Immediate-release verapamil should be initiated at 40 mg three times daily. [1]
-
Dose titration should proceed based on response and tolerability. [1],[2]
Initiation Thresholds and Patient-Specific Checks
- Verapamil should be avoided or used with significant caution in patients with conditions where verapamil is contraindicated or where serious adverse effects are likely, including those in whom verapamil is not suitable per labeling. [4]
- Baseline cardiovascular assessment should include blood pressure and heart rate before initiation because verapamil can lower blood pressure and slow heart rate. [3],[4]
Monitoring During the Transition
- Blood pressure and heart rate should be monitored during initiation and titration of verapamil to detect hypotension and bradycardia. [3],[4]
- Adverse effects requiring urgent reassessment include symptoms consistent with marked bradycardia or heart block. [3],[4]
Common Pitfalls to Avoid
- Verapamil should not be initiated at high doses without titration because verapamil’s dose-related effects on heart rate and blood pressure can occur. [1],[2]
- Verapamil should be withheld in patients where verapamil is not appropriate according to contraindication guidance. [4]
Targets of Therapy
Blood pressure control should be reassessed after the medication transition and titration to reach guideline-directed blood pressure goals using serial measurements and medication dose adjustment. [7]
Key Contraindications and Safety Considerations
Verapamil has specific contraindications and “who can and cannot take verapamil” guidance that should be reviewed before initiation. [4] Verapamil can be associated with hypotension and heart block. [3],[4]